Parallel18 is a global startup accelerator and investment platform based in Puerto Rico. It was created as a program of the Puerto Rico Science, Technology, and Research Trust, a private non-profit organization aimed at enhancing Puerto Rico's role in the global knowledge economy. Parallel18 provides startup founders with access to business training, mentorship, connections, and investment resources to facilitate their growth and scalability.

Parallel18 invests in startups through various programs, including BioLeap, an incubation program for life sciences entrepreneurs; the International Acceleration Program (P18), which offers a $100,000 investment via a SAFE; and Xpand, a growth-stage program for local startups. The organization aims to identify startups with high potential for global scale and provide them with the necessary support to succeed.

Parallel18 offers a unique hybrid grant+SAFE investment structure, providing $40,000 as an equity-free grant and $20,000 as a SAFE investment. This allows founders to receive significant funding with minimal equity dilution. Additionally, the program provides mentorship, business training, and access to a global network.

Q: What is the investment structure? A: Parallel18 provides a total of $60,000 per company, consisting of a $40,000 equity-free grant and a $20,000 SAFE investment. Q: What is the survival rate of startups? A: The survival rate is 92%, which is significantly higher than the industry average.